Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|December 22, 2023
A novel "turn-on" fluorescent probe based on thiocarbamoyl-DHP for Hg2+ detection in water samples and living cellsWaroton Paisuwan, Tanapat Palaga, Thitiporn Pattarakankul, et al.
Chemical Science|August 2, 2019
Nickel-catalyzed decarbonylation of N-acylated N-heteroarenesToshifumi Morioka, Syun Nakatani, Yuki Sakamoto, et al.
RSC Advances|May 2, 2022
Correction: Oxovanadium(v)-catalyzed amination of carbon dioxide under ambient pressure for the synthesis of ureasToshiyuki Moriuchi, Takashi Sakuramoto, Takanari Matsutani, et al.
RSC Advances|April 28, 2022
Oxovanadium(v)-catalyzed amination of carbon dioxide under ambient pressure for the synthesis of ureasToshiyuki Moriuchi, Takashi Sakuramoto, Takanari Matsutani, et al.
Journal of the American Chemical Society|July 2, 2026
Photoinduced Disproportionation Enables Oxidative Addition of Aryl Iodides at a Gallium(I) CenterNijito Mukai, Sota Iwasaki, Manaya Kawasaki, et al.
Organic Letters|March 21, 2018
Synthesis and Isomerization Behavior of a Macrocycle with Four Photoresponsive MoietiesToru Amaya, Hayato Fujimoto, Takahiro Tanaka, et al.
Bioorganic & Medicinal Chemistry|January 1, 2008
Discovery of piperazinylimidazo[1,2-a]pyridines as novel S4 binding elements for orally active factor Xa inhibitorsYasuhiro Imaeda, Tetsuji Kawamoto, Mamoru Tobisu, et al.
Organic Letters|August 4, 2023
Synthesis and Host-Guest Chemistry of Chiral Spirobifluorene-Based Macrocycles Soluble in Basic Aqueous SolutionKotoko Nakagawa, Kanaru Akimoto, Bunta Nakayasu, et al.
Clinical Biomechanics (Bristol, Avon)|November 5, 2025
Comparing the effect of short foot exercise and toe curl exercise on plantar pressure during single-leg standing in individuals with flatfoot: A randomized controlled trialMisaki Suzuki, Hironobu Kuruma, Kunihiro Kato, et al.
Journal of Medicinal Chemistry|May 30, 2008
Discovery of imidazo[1,5-c]imidazol-3-ones: weakly basic, orally active factor Xa inhibitorsYasuhiro Imaeda, Takanobu Kuroita, Hiroki Sakamoto, et al.
Pageof 13